P46 - PSA Nadir predicts therapy response in metastatic hormone-sensitive prostate cancer treated by new hormonal agents or chemotherapy
- Resource Type
- Abstract
- Source
- In
European Urology Open Science October 2022 44 Supplement 2:S219-S219 - Subject
- Language
- ISSN
- 2666-1683